COMPANY
Wntrix
NIH awards 2
- NIH award 1R41CA281553-01 FY2023: $400,000 awarded for that fiscal year; activity R41 (STTR); PI CUI, JIE; recipient as written: WNTRIX, INC., Houston, TX. Development of drug conjugates of R-spondin peptibodies for source ↗
- NIH award 1R41CA213479-01A1 FY2017: $225,000 awarded for that fiscal year; activity R41 (STTR); PI CUI, JIE; recipient as written: WNTRIX, INC., Houston, TX. Investigation of antibody-drug conjugates of a novel targe source ↗